Table 1 |
|||||||||
|
Characteristics of subjects with positive serologic antibodies for gluten-sensitive enteropathy |
|||||||||
|
Patient no. |
sex |
age |
Duration of RAS(y) |
No. of attacks per year |
Response to conventional therapy |
serology |
Marsh classification |
Other symptoms |
Improvement with GFD |
|
|
|||||||||
|
1 |
F |
13 |
2 |
12< |
No |
tTG + |
II |
Anemia |
Yes |
|
|
|||||||||
|
2 |
M |
33 |
5 |
12< |
No |
tTG + |
I |
No |
-- |
|
|
|||||||||
|
3 |
F |
40 |
7 |
6 to12 |
No |
tTG + |
I |
No |
--- |
|
|
|||||||||
|
4 |
M |
40 |
6 |
6 to12 |
No |
tTG + |
I |
No |
---- |
|
|
|||||||||
|
5 |
M |
18 |
3 |
12< |
No |
AEA+ & tTG+ |
III |
Anemia |
Yes |
|
|
|||||||||
|
6 |
M |
25 |
5 |
12< |
No |
tTG + |
I |
No |
Yes |
|
|
|||||||||
|
7 |
F |
23 |
4 |
6 to12 |
No |
tTG + |
II |
No |
Yes |
|
|
|||||||||
|
tTG: tissue transglutaminase antibody, EMA: anti endomysial antibody. |
|||||||||
|
Shakeri et al. BMC Gastroenterology 2009 9:44 doi:10.1186/1471-230X-9-44 |
|||||||||
